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Abstract: 
This is the first case report from its kind to be reported from the Institute of nuclear 
medicine, Molecular Biology University of Gezira. It is a case report of a 30-years old lady 
diagnosed as having choriocarcinoma, gestational trophoblastic tumor, and treated with 
multiple agent chemotherapy for three months. She was advised not to get pregnant during 
the first two years following chemotherapy. She was on regular follow up for one year after 
which she disappeared and discontinued the contraceptive pills. Seven months later she 
presented with a viable pregnancy and was followed till she delivered a normal viable alive 




 ةلاحلا هذه .ةريزجلا ةعماجب مارولأا جلاعو ىوونلا بطلا دهعم نم مدقت ىتلاو اهعون نم ىلولأا ىه ةلاحلا هذه
 رمعلا نم غلبت ةارملأ ةيبطلا03  ثلاث ةدمل ةددعتملا ةيئايميكلا ريقاقعلاب تجلوعو ةيئامشملا ةناطرسب اهصيخشت مت ةنس
ب ضيرملا حصن مت .روهش تباغ ةعباتملا نم لولأا ماعلا لامكإ دعب .جلاعلا لامكإ دعب نيتنس ةدم لمحلا بنجت ةرورض
 نيرهش هرمع ىح نينجب ىلبح ىهو رهشأ ةعبسب كلذ دعب ةديسلا ترضح .لمحلا عنام لوانت تفقوأو روضحلا نع ةديسلا
عوضولا نم رهشأ ةتس رورم دعب .ًاركذ ًاحيحص ًادلو تعضو ىتح اهتعباتم تمتو  ىف ىهو ةعباتملل ةديسلا ترضح
.اهلفط كلذكو ةديج ةلاح
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Introduction 
Choriocarcinoma is a malignant disease of gestational trophoblast. It can cause 
serious localized and metastatic disease. Since discovery of several chemotherapeutics 
agents against the disease, sustained remission rate approaching 90% in metastatic disease 
and nearly 100% in localized disease 1, 2, 3. Pregnancy after successful treatment of 
Choriocarcinoma can and does occur but, we need not to forget the hazards of these drugs 
use in treatment of Choriocarcinoma. Patients who achieved primary remission with various 
kinds of chemotherapy may anticipate a normal future reproductive outcome. As 
pregnancies occurring within 6 months following remission are at risk of abnormality, a 
waiting period of at least 6 months after chemotherapy for GTT is recommended 4, 5. The 
large number of successful pregnancies reported after treatment reflects the potential high 
rates of cure and survival 6, 7. The following is the first case report of a normal pregnancy 
following treatment of moderate risk case of Choriocarcinoma in our institute. 
 
Case report 
A lady of thirty years old married for nine years and had three alive vaginal deliveries. She 
presented to the Gynecological clinic in Wadmedani teaching hospital with vaginal bleeding 
and Amenorrhea for 2 months. She was diagnosed as a case of incomplete abortion and 
evacuation was done but patient didn't take the products for histopathology. Two months 
later she presented with intermittent vaginal bleeding. On examination she was very ill, pale, 
uterus size 16 weeks and there was a mass coming through the cervix into the vagina. 
Investigations showed low haemoglobin and clear lungs on CXR. Sonography revealed a 
uterine mass with dense vesicles, other abdominal organs were free. Immunologic assay for 
gonadotrophin (Beta HCG) was reported as greater than 1000000IU/l. Brain imaging was 
unaffordable. After transfusion of 3 units of blood she had an evacuation operation. The 
specimen sent to histopathologist who confirmed the diagnosis of Choriocarcinoma. 
According to modified WHO scoring system she was categorized in the medium risk group. 
Patient then referred to oncology center and started on single agent Methotrexate 
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chemotherapy for two weeks but bleeding continued, so she was shifted to poly-
chemotherapy (EMA CO) which is composed of Etoposide, Methotrexate, Vincristine, 
Cyclophosphamide and cisplatinum plus Folinic acid as rescue drug for methotrexate. After 
one cycle the bleeding stopped completely and after four cycles the Beta HCG became 
normal (3.05IU/l). Additional two cycles were given after Beta HCG normalization, then 
treatment stopped. She remained on regular follow up using clinical examination monthly 
and Beta HCG assay every 2-4 weeks. Patient was advised not to get pregnant for at least 2 
years and was put on oral contraception. Patient remained free for 1 year after that she 
disappeared and lost follow up for 7 months. Seven months later she presented carrying a 
viable pregnancy with gestation age of 9 weeks. Total period between cessation of 
chemotherapy and conceiving was 17 months. Uneventful pregnancy was followed and she 
delivered vaginally a term normal viable male baby. The placenta and membranes were 
delivered complete and normal. Immediate after delivery value of Beta HCG was 40 U/L. 
Patient was last seen two months after delivery, both she and her baby were healthy and the 
Value of Beta HCG was normal (1.02IU/l). 
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Discussion: 
Gestational trophoblastic diseases describe a dynamic interrelated biological process 
involving the fetal chorion. It is of great importance to identify and separate the high risk 
cases in order to establish prompt and adequate treatment. Prolongation of the duration 
between treatment and antecedent pregnancy has negative impact on prognosis 8.  .Beta 
HCG has a central role in diagnosis; management and prognosis of patients with gestational 
trophoblastic neoplasm and it represents an ideal tumor marker.  Several diagnostic 
procedures are to be followed to determine the extension of disease. These include 
periodical physical examination, Beta HCG assay, CXR and imaging for liver and brain. 
Transvaginal Doppler ultrasonographic findings are not always in correlation with Beta 
HCG level in the beginning of the diagnosis and during various stages of treatment 9. It was 
suggest that contraception for 1 year is necessary in patients with GTT after successful 
chemotherapy. However, in the case of a patient who conceives within 1 year, it is not 
necessary to terminate pregnancy, but the pregnancy must be carefully watched10.  
 Nicolic from University of Belgrade reported four successful pregnancies among 14 cases 
of malignant trophoblastic disease during the period from 1999-2004 without 
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